paxilline has been researched along with Squamous Cell Carcinoma of Head and Neck in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SD; Shin, JA; Yu, HJ | 1 |
| Asiedu, EB; Hefni, E; Ma, T; Meiller, T; Menon, D; Montaner, S; Schneider, A; Sodhi, A; Sultan, A | 1 |
| Bekiranov, S; Gioeli, D; Hall, S; Jameson, MJ; Lehman, CE; Petricoin, EF; Shaw, JJP; Spencer, A; Wulfkuhle, J | 1 |
3 other study(ies) available for paxilline and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Inhibition of focal adhesion kinase/paxillin axis by caffeic acid phenethyl ester restrains aggressive behaviors of head and neck squamous cell carcinoma in vitro.
Topics: Cadherins; Caffeic Acids; Cell Line, Tumor; Cell Movement; Focal Adhesion Protein-Tyrosine Kinases; Head and Neck Neoplasms; Humans; Paxillin; Phenylethyl Alcohol; Squamous Cell Carcinoma of Head and Neck | 2023 |
Angiopoietin-like 4 induces head and neck squamous cell carcinoma cell migration through the NRP1/ABL1/PXN pathway.
Topics: Angiopoietins; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Head and Neck Neoplasms; Humans; Neuropilin-1; Paxillin; Squamous Cell Carcinoma of Head and Neck | 2023 |
IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dasatinib; Drug Synergism; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Indoles; Paxillin; Phosphorylation; Protein Array Analysis; Pyrazoles; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Sulfonamides; Triazines | 2021 |